Pfizer has urged a US Court of Appeals to uphold a decision to dismiss a lawsuit from an anti-affirmative action group that challenged its diversity fellowship program. The US Court of Appeals for the Second Circuit dismissed Do No Harm’s lawsuit because the group failed to name at least one individual harmed by Pfizer’s program. The lawsuit against Pfizer The case involves Pfizer’s fellowship program aimed at recruiting and training Black, Latine, and Native American leaders. Do No Harm’s lawsuit claims the program violated federal civil rights laws. In March,
VC firm Fearless Fund has faced another setback in its plans to issue grants to Black women business owners as the court has ruled against them. On Monday, an appeals court for the 11th Circuit ruled against Fearless, upholding a preliminary injunction against their Strivers Grant program. The court ruling said that the grant likely violates the Civil Rights Act of 1886, which bans the use of race in contracts. What Has Happened So Far? The American Alliance for Equal Rights (AAER), founded by Edward Blum, attacked the Fearless Fund
